Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 25

CN56 - Well-being and healthcare concerns of patients with advanced renal cell carcinoma: The RCC PROMs international survey

Date

21 Oct 2023

Session

Poster session 25

Topics

Psychosocial Aspects of Cancer

Tumour Site

Renal Cell Cancer

Presenters

Grigorios Kotronoulas

Citation

Annals of Oncology (2023) 34 (suppl_2): S1229-S1256. 10.1016/annonc/annonc1321

Authors

G. Kotronoulas1, C. Diez de los Rios de la Serna2, A. Drury3, W.H. Oldenmenger4, D. Kelly5

Author affiliations

  • 1 School Of Medicine, Dentistry & Nursing, University of Glasgow, G12 8QQ - Glasgow/GB
  • 2 Medicine, Dentistry And Nursing, University of Glasgow, G12 8QQ - Glasgow/GB
  • 3 School Of Nursing, Psychotherapy And Community Health, DCU - Dublin City University, D09 V209 - Dublin/IE
  • 4 Medical Oncology, Erasmus MC Cancer Institute, 3015 GD - Rotterdam/NL
  • 5 School Of Healthcare Sciences, Cardiff University - School of Healthcare Sciences, CF24 0AB - Cardiff/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN56

Background

Renal cell carcinoma (RCC) is the most common type of kidney cancer, most frequently diagnosed in men over 60 and in higher-income settings. Around 30% of cases are of advanced RCC. Despite progress with targeted therapies and immunotherapy, patients with advanced RCC face difficulties with day-to-day living. Patient-reported outcomes provide crucial information to enhance clinicians’ understanding about what issues patients perceive to have the greatest impact on them and can help promote person-centred approaches to treatment and disease management.

Methods

As part of the larger EONS PROMs project (https://cancernurse.eu/research/proms_project/), an international online survey was launched in May 2022. With a sampling confidence level of 95% and a margin of error of 10%, we aimed to involve ≥89 patients with advanced RCC. The survey comprised a bespoke demographic/clinical form, the Functional Assessment of Cancer Therapy-Biologic Response Modifiers (FACT-BRM) questionnaire, and three questions on patients’ priority concerns.

Results

The survey included 105 patients. Typically, patients were men (n=62, 59%), on targeted therapy (n=31, 33.7%), middle-aged (median=44 years), and over 3 years since diagnosis (median=37 months). Descriptive analysis of individual FACT-BRM items revealed that patients: were bothered by too frequent an urge to urinate (70%), worried their condition will worsen (68%), worried about their partner or family (67%), felt helpless (60%), were unable to work (59%), and were concerned about end-of-life care (58%). Spontaneously, patients identified major concerns with wages, impact on family, and future response to treatment. Older age was a statistically significant predictor of higher FACT-BRM total scores (p<0.001), better physical wellbeing (p<0.001), and better emotional wellbeing (p<0.001). Receiving radiotherapy or targeted therapy were predictive of poorer physical wellbeing (p<0.05).

Conclusions

Identifying, monitoring, and responding to concerns relating to physical, emotional, social, and practical aspects of wellbeing can be meaningful steps towards provision of enhanced person-centred care in advanced RCC.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Ipsen Pharma; Eisai.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.